Cargando…
Neurotensin Receptor-1 Expression in Human Prostate Cancer: A Pilot Study on Primary Tumors and Lymph Node Metastases
Neurotensin and its high-affinity receptor, NTR(1), are involved in the growth of various tumors. Few data are available regarding NTR(1) expression in normal and tumoral human prostate tissue samples. NTR(1) expression was assessed using immunohistochemistry in 12 normal prostate tissues, 11 benign...
Autores principales: | Morgat, Clément, Chastel, Adrien, Molinie, Vincent, Schollhammer, Romain, Macgrogan, Gaétan, Vélasco, Valérie, Malavaud, Bernard, Fernandez, Philippe, Hindié, Elif |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6479796/ https://www.ncbi.nlm.nih.gov/pubmed/30959962 http://dx.doi.org/10.3390/ijms20071721 |
Ejemplares similares
-
Comparison of the binding of the gastrin-releasing peptide receptor (GRP-R) antagonist (68)Ga-RM2 and (18)F-FDG in breast cancer samples
por: Morgat, Clément, et al.
Publicado: (2019) -
Design, Synthesis,
and Biological Evaluation of the
First Radio-Metalated Neurotensin Analogue Targeting Neurotensin Receptor
2
por: Bodin, Sacha, et al.
Publicado: (2023) -
(68)Ga-Radiolabeling and Pharmacological Characterization of a Kit-Based Formulation of the Gastrin-Releasing Peptide Receptor (GRP-R) Antagonist RM2 for Convenient Preparation of [(68)Ga]Ga-RM2
por: Chastel, Adrien, et al.
Publicado: (2021) -
Theranostics of Primary Prostate Cancer: Beyond PSMA and GRP-R
por: Schollhammer, Romain, et al.
Publicado: (2023) -
Comparison of the radiolabeled PSMA-inhibitor (111)In-PSMA-617 and the radiolabeled GRP-R antagonist (111)In-RM2 in primary prostate cancer samples
por: Schollhammer, Romain, et al.
Publicado: (2019)